Short Interest in NuCana plc Decreases By 63.2
NCNA Stock | USD 1.26 0.04 3.08% |
About 61% of NuCana PLC's investor base is looking to short. The analysis of the overall investor sentiment regarding NuCana PLC suggests that many traders are alarmed. The current market sentiment, together with NuCana PLC's historical and current headlines, can help investors time the market. In addition, many technical investors use NuCana PLC stock news signals to limit their universe of possible portfolio assets.
NuCana |
NuCana plc saw a significant drop in short interest in January. As of January 31st, there was short interest totalling 72,900 shares, a drop of 63.2 percent from the January 15th total of 198,200 shares. Currently, 0.2 percent of the companys stock are short sold. Based on an average daily trading volume, of
Read at thelincolnianonline.com
NuCana PLC Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards NuCana PLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
NuCana PLC Fundamental Analysis
We analyze NuCana PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NuCana PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NuCana PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
NuCana PLC is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
NuCana PLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NuCana PLC stock to make a market-neutral strategy. Peer analysis of NuCana PLC could also be used in its relative valuation, which is a method of valuing NuCana PLC by comparing valuation metrics with similar companies.
Peers
NuCana PLC Related Equities
ALXO | Alx Oncology | 12.16 | ||||
VINC | Vincerx Pharma | 3.57 | ||||
ABOS | Acumen Pharmaceuticals | 3.52 | ||||
SLN | Silence Therapeutics | 3.28 | ||||
INZY | Inozyme Pharma | 2.95 | ||||
CTMX | CytomX Therapeutics | 2.83 | ||||
MREO | Mereo BioPharma | 0.55 | ||||
TNYA | Tenaya Therapeutics | 0.28 | ||||
DAWN | Day One | 0.65 | ||||
RANI | Rani Therapeutics | 0.99 | ||||
ZVSA | ZyVersa Therapeutics | 3.74 | ||||
CDTX | Cidara Therapeutics | 7.17 | ||||
ZURA | Zura Bio | 8.20 | ||||
CRVS | Corvus Pharmaceuticals | 9.24 | ||||
APLT | Applied Therapeutics | 13.79 |
Complementary Tools for NuCana Stock analysis
When running NuCana PLC's price analysis, check to measure NuCana PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NuCana PLC is operating at the current time. Most of NuCana PLC's value examination focuses on studying past and present price action to predict the probability of NuCana PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NuCana PLC's price. Additionally, you may evaluate how the addition of NuCana PLC to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |